Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
暂无分享,去创建一个
M. Levine | M. Cruickshank | J. Weitz | B. Leslie | T. Eckhardt | J. Ginsberg | B. Thong | J. Weitz | Moira Cruickshank | Mark N. Levine | Jeffrey S. Ginsberg
[1] S. Haas,et al. MEASUREMENT OF ELASTASE-INDUCED FIBRINOGEN-DERIVED PEPTIDES IN VITRO , 1987, Thrombosis and Haemostasis.
[2] R Roberts,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.
[3] K. Friedman,et al. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator. , 1987, The Journal of clinical investigation.
[4] W R Bell,et al. A kinetic analysis of fibrinogenolysis during plasminogen activator therapy , 1987, Clinical pharmacology and therapeutics.
[5] J. Weitz,et al. Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency. , 1986, The Journal of clinical investigation.
[6] I. Palacios,et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.
[7] E. Braunwald,et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. , 1986, Circulation.
[8] E. Topol,et al. Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study. , 1985, Annals of internal medicine.
[9] D. Collen,et al. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. , 1985, The Journal of pharmacology and experimental therapeutics.
[10] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[11] Gary Halvorson,et al. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Verstraete M, Bory M, Erbel R, et al Lancet 842–847 Apr 13, 1985 , 1985 .
[12] P. Wallén,et al. In vivo metabolism of human tissue-type plasminogen activator. , 2009, Scandinavian journal of haematology.
[13] B E Sobel,et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.
[14] L. Harker,et al. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. , 1984, The Journal of clinical investigation.
[15] M. Rånby,et al. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. , 1982, Biochimica et biophysica acta.
[16] M. Hoylaerts,et al. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.
[17] Fibrinolytic Pathway. Leukocyte Elastase Release during Blood Coagulation A POTENTIAL MECHANISM FOR ACTIVATION OF THE ALTERNATIVE , 1982 .
[18] D. Collen,et al. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.
[19] H. Nossel,et al. Measurement of desarginine fibrinopeptide B in human blood. , 1981, The Journal of clinical investigation.
[20] D. Loskutoff. Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells. , 1979, The Journal of clinical investigation.
[21] C. Kluft. Studies on the Fibrinolytic System in Human Plasma: Quantitative Determination of Plasminogen Activators and Proactivators , 1979, Thrombosis and Haemostasis.
[22] H. Nossel,et al. The stability of fibrinopeptide B immunoreactivity in blood. , 1978, Thrombosis research.
[23] R. Canfield,et al. Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A. , 1976, Biochemistry.
[24] R. Canfield,et al. Immunochemical studies of human fibrinopeptide A using synthetic peptide homologues. , 1976, Biochemistry.
[25] R. Canfield,et al. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. , 1975, The Journal of clinical investigation.
[26] R. Canfield,et al. Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.
[27] R. Lundblad. A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride. , 1971, Biochemistry.
[28] R. B. Merrifield,et al. Chemical synthesis of peptides and proteins. , 1970, Annual review of biochemistry.